CDH2 and breast cancer: One of the hallmarks of EMT is the loss of the E-Cadherin, and the concomitant increase in expression of the mesenchymal cell-cell adhesion molecule N-Cadherin, a process also known as the Cadherin switch[42,43], which can provoke cell migration and invasion in breast cancer cells[44,45].